Citation: Rs. Kerbel, NEW TARGETS, DRUGS, AND APPROACHES FOR THE TREATMENT OF CANCER - AN OVERVIEW, Cancer metastasis reviews, 17(2), 1998, pp. 145-147
Authors:
WITTE L
HICKLIN DJ
ZHU ZP
PYTOWSKI B
KOTANIDES H
ROCKWELL P
BOHLEN P
Citation: L. Witte et al., MONOCLONAL-ANTIBODIES TARGETING THE VEGF RECEPTOR-2 (FLK1 KDR) AS AN ANTI-ANGIOGENIC THERAPEUTIC STRATEGY/, Cancer metastasis reviews, 17(2), 1998, pp. 155-161
Citation: P. Atadja et al., PSC-833, A FRONTIER IN MODULATION OF P-GLYCOPROTEIN MEDIATED MULTIDRUG-RESISTANCE, Cancer metastasis reviews, 17(2), 1998, pp. 163-168
Citation: C. Blancher et Al. Harris, THE MOLECULAR-BASIS OF THE HYPOXIA RESPONSE PATHWAY - TUMOR HYPOXIA AS A THERAPY TARGET, Cancer metastasis reviews, 17(2), 1998, pp. 187-194
Citation: Dh. Yu et Mc. Hung, THE ERBB2 GENE AS A CANCER THERAPEUTIC TARGET AND THE TUMOR-SUPPRESSING AND METASTASIS-SUPPRESSING FUNCTION OF E1A, Cancer metastasis reviews, 17(2), 1998, pp. 195-202
Citation: Ld. Mayer, FUTURE-DEVELOPMENTS IN THE SELECTIVITY OF ANTICANCER AGENTS - DRUG-DELIVERY AND MOLECULAR TARGET STRATEGIES, Cancer metastasis reviews, 17(2), 1998, pp. 211-218
Citation: Rw. Haq et B. Zanke, INHIBITION OF APOPTOTIC SIGNALING PATHWAYS IN CANCER-CELLS AS A MECHANISM OF CHEMOTHERAPY RESISTANCE, Cancer metastasis reviews, 17(2), 1998, pp. 233-239
Citation: G. Siemeister et al., THE PIVOTAL ROLE OF VEGF IN TUMOR ANGIOGENESIS - MOLECULAR FACTS AND THERAPEUTIC OPPORTUNITIES, Cancer metastasis reviews, 17(2), 1998, pp. 241-248
Citation: D. Spaner, GEOGRAPHICAL CONSIDERATIONS REGARDING DONOR LEUKOCYTE INFUSIONS FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MALIGNANCIES, Cancer metastasis reviews, 17(2), 1998, pp. 249-257
Citation: Pk. Lala, SIGNIFICANCE OF NITRIC-OXIDE IN CARCINOGENESIS, TUMOR PROGRESSION ANDCANCER-THERAPY, Cancer metastasis reviews, 17(1), 1998, pp. 1-6
Citation: Je. Albina et Js. Reichner, ROLE OF NITRIC-OXIDE IN MEDIATION OF MACROPHAGE CYTOTOXICITY AND APOPTOSIS, Cancer metastasis reviews, 17(1), 1998, pp. 39-53
Citation: Kp. Xie et Ij. Fidler, THERAPY OF CANCER METASTASIS BY ACTIVATION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE, Cancer metastasis reviews, 17(1), 1998, pp. 55-75
Citation: D. Fukumura et Rk. Jain, ROLE OF NITRIC-OXIDE IN ANGIOGENESIS AND MICROCIRCULATION IN TUMORS, Cancer metastasis reviews, 17(1), 1998, pp. 77-89
Citation: Pk. Lala et A. Orucevic, ROLE OF NITRIC-OXIDE IN TUMOR PROGRESSION - LESSONS FROM EXPERIMENTAL-TUMORS, Cancer metastasis reviews, 17(1), 1998, pp. 91-106
Citation: Ll. Thomsen et Dw. Miles, ROLE OF NITRIC-OXIDE IN TUMOR PROGRESSION - LESSONS FROM HUMAN TUMORS, Cancer metastasis reviews, 17(1), 1998, pp. 107-118
Citation: H. Shahidi et Rg. Kilbourn, THE ROLE OF NITRIC-OXIDE IN INTERLEUKIN-2 THERAPY INDUCED HYPOTENSION, Cancer metastasis reviews, 17(1), 1998, pp. 119-126
Citation: A. Orucevic et Pk. Lala, ROLE OF NITRIC-OXIDE IN IL-2 THERAPY-INDUCED CAPILLARY LEAK SYNDROME, Cancer metastasis reviews, 17(1), 1998, pp. 127-142